🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
16.69
+0.07 (0.42%)
Nov 20, 2026, 10:01 AM EST - Market open

Xeris Biopharma Holdings Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
131.08111.0471.6267.45121.9767.27
Short-Term Investments
---5-35.16
Cash & Short-Term Investments
131.08111.0471.6272.45121.97102.43
Cash Growth
43.11%55.04%-1.15%-40.60%19.07%-23.44%
Accounts Receivable
68.651.0540.4239.230.8317.46
Receivables
68.651.0540.4239.230.8317.46
Inventory
76.9368.6748.1838.8424.7418.12
Prepaid Expenses
12.669.557.455.789.294.59
Total Current Assets
289.27240.31167.66156.26186.82142.6
Property, Plant & Equipment
26.2227.0628.2129.189.516.63
Goodwill
22.8622.8622.8622.8622.8622.86
Other Intangible Assets
79.9588.0898.92109.76120.61131.45
Other Long-Term Assets
4.935.225.414.544.730.83
Total Assets
423.22383.53323.06322.6344.52304.36

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
8.043.082.2911.574.618.92
Accrued Expenses
98.3976.4156.845.6644.0951.17
Current Portion of Long-Term Debt
--15.1---
Current Portion of Leases
6.356.236.083.51.58-
Current Unearned Revenue
3.9-----
Other Current Liabilities
17.823.8620.1734.4723.3518.95
Total Current Liabilities
134.48109.57100.4495.1973.6279.04
Long-Term Debt
189.71220.34217.01190.93187.0888.07
Long-Term Leases
3031.5333.2634.769.4-
Long-Term Deferred Tax Liabilities
---2.273.524.94
Other Long-Term Liabilities
17.948.41.976.2325.7237.08
Total Liabilities
374.44369.84352.68329.38299.34209.13

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.020.020.010.010.01
Additional Paid-In Capital
737.66685642.26610.25599.97555.36
Retained Earnings
-688.88-671.31-671.86-617.03-554.77-460.11
Comprehensive Income & Other
-0.01-0.03-0.03-0.03-0.02-0.03
Total Common Equity
48.7813.69-29.62-6.7845.1995.23
Shareholders' Equity
48.7813.69-29.62-6.7845.1995.23
Total Liabilities & Equity
423.22383.53323.06322.6344.52304.36

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
226.07258.1271.45229.19198.0688.07
Net Cash (Debt)
-94.98-147.06-199.83-156.74-76.0914.37
Net Cash Growth
------69.28%
Net Cash Per Share
-0.55-0.85-1.36-1.14-0.560.18
Filing Date Shares Outstanding
182.7172.43153.94140.45137.29135.52
Total Common Shares Outstanding
182.57166.22149.43138.13136.27124.87
Working Capital
154.79130.7467.2261.07113.263.56
Book Value Per Share
0.270.08-0.20-0.050.330.76
Tangible Book Value
-54.02-97.25-151.4-139.41-98.28-59.08
Tangible Book Value Per Share
-0.30-0.59-1.01-1.01-0.72-0.47
Machinery
7.046.916.265.655.685.43
Leasehold Improvements
5.75.76.065.985.075.03
SEC Filings: 10-K · 10-Q